FAQ

L-FABP

Samples, measurement

Product performance/operation

Research use

Q1
What is L-FABP?
A1
L-FABP stands for “L-type Fatty Acid Binding Protein” and is a low molecular weight soluble protein (14 kDa) that is specifically expressed in the liver and renal proximal tubules. Because L-FABP is a substance derived from the cytoplasm of the renal proximal tubules and is excreted in urine due to renal tubular ischemia and oxidative stress on renal tubules, urinary L-FABP is useful for early diagnosis of renal disease accompanying tubular dysfunction.
Q2
Is liver-derived L-FABP excreted in urine?
A2
Usually L-FABP excreted by liver is reabsorbed by kidney in healthy condition and it is not or almost not excreted in urine. However, when liver origin L-FABP is no longer reabsorbed by the kidney, it is excreted in urine.
In the case of the fulminant hepatitis and hepatorenal syndrome, approximately 12% of urinary L-FABP is from the liver, but liver-derived L-FABP can be easily distinguish from kidney-derived L-FABP by using in combination with other biomarkers.
Q3
How is L-FABP different from urinary albumin?
A3
Urinary albumin is a glomerular injury marker that indicates the result of filtration failure. Its quantity excreted in the urine increases with the progression of the glomerular injury. In contrast, L-FABP is a marker reflecting tubular dysfunction, and is excreted in the urine in response to ischemia and oxidative stress.
Q4
What is the clinical utility of L-FABP?
A4
If you are interested in the clinical utility of L-FABP, please click here. Clinical Utilities
NEWS

New articles related to L-FABP were released.

New articles related to L-FABP were released.

New articles related to L-FABP were released.

New articles related to L-FABP were released.

New articles related to L-FABP were released.

New articles related to L-FABP were released.
TOP